4//SEC Filing
NEULION, INC. 4
Accession 0001214659-16-010592
CIK 0001387713operating
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 5:41 PM ET
Size
12.2 KB
Accession
0001214659-16-010592
Insider Transaction Report
Form 4
LI NANCY
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2016-03-29$0.78/sh+63,930$50,000→ 51,687,437 total(indirect: By Spouse) - Purchase
Common Stock
2016-03-29$0.87/sh+1,500,000$1,304,250→ 53,187,437 total(indirect: By Spouse)
Holdings
- 40,150,056
Common Stock
- 28,020(indirect: By Trust)
Common Stock
- 28,020(indirect: By Trust)
Common Stock
- 750,000
Restricted Common Stock
- 750,000
Restricted Common Stock
Footnotes (7)
- [F1]Ms. Li's spouse, Charles B. Wang, the Chairman of the Board of NeuLion, purchased these shares from J. Christopher Wagner, the Executive Vice President, Marketplace Strategy, of NeuLion.
- [F2]The purchase price of each share was $0.7821, which was the 5 day volume weighted average price of NeuLion's common stock on the Toronto Stock Exchange ending March 28, 2016.
- [F3]Multiple same-way open market purchases effected on the same day within a one dollar price range are reported on this line. The figure in the price column is the weighted average purchase price for these transactions. These trades were executed on the Aequitas NEO Exchange, Alpha ATS, Nasdaq CX, Nasdaq CX2, TriAct MATCH Now, Omega ATS, Canadian Securities Exchange and the Toronto Stock Exchange, and the purchase prices were in Canadian dollars. The purchase price per share for each trade was between Cdn$1.09 and Cdn$1.16. The purchase prices were converted to US dollars by the executing broker, Merrill Lynch, at a rate of 0.7591. The reporting person undertakes to provide, upon request by the Commission staff, NeuLion, Inc., or a security holder of NeuLion, Inc., full information regarding the number of shares purchased at each separate price.
- [F4]Ms. Li is the trustee for the two trusts and her children are the beneficiaries of the trusts.
- [F5]The reporting person was granted these restricted shares subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The restricted shares vest at a rate of one-quarter of their allotted amount per year over four years. Vesting began on March 7, 2016.
- [F6]The reporting person was granted these restricted shares subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The restricted shares vest at a rate of one-quarter of their allotted amount per year over four years. Vesting began on May 18, 2015.
- [F7]Ms. Li disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Ms. Li is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
NEULION, INC.
CIK 0001387713
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001387713
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 5:41 PM ET
- Size
- 12.2 KB